According to the latest report by IMARC Group, titled “Europe Biopsy Devices Market Size, Share, Trends and Forecast by Procedure Type, Product, Application, Guidance Technique, End User, and Region, 2026-2034,” the Europe biopsy devices market size reached USD 666.0 Million in 2025🅷. Biopsy devices are specialized medical instruments designed to obtain tissue samples from the human body for diagnostic purposes. These devices play a crucial role in the early detection and accurate diagnosis of various medical conditions, including cancers and other diseases. They enable healthcare professionals to extract tissue samples in a minimally invasive (MI) manner, reducing patient discomfort and recovery time. Biopsy devices are available in various types, including needle-based, vacuum-assisted, and surgical biopsy tools, each catering to specific clinical requirements. These devices are integral to modern healthcare practices, aiding clinicians in making informed treatment decisions based on precise pathological insights.

Europe Biopsy Devices Market Trends:

The increasing prevalence of cancer and chronic diseases across the region, intensifying the demand for accurate and efficient diagnostic tools, is one of the major factors contributing to the market growth. In line with this, the growing application of biopsy devices for early detection, personalized treatment approaches, and providing precise tissue samples for analysis is propelling the market growth. Additionally, rapid technological advancements and innovations in biopsy techniques, such as image-guided biopsies and minimally invasive (MI) procedures, enhancing accuracy while reducing patient discomfort and risks are strengthening the market growth. Moreover, the growing emphasis on research and development (R&D) within the medical industry leading to the creation of biopsy devices that offer higher precision and better compatibility with various imaging modalities, particularly crucial in the field of oncology, is creating a positive outlook for the market growth. In addition to this, the growing focus of regulatory bodies on patient safety and device quality, prompting manufacturers to improve the safety and effectiveness of biopsy devices, resulting in cutting-edge technology and adherence to international standards, is fueling the market growth. Furthermore, the transition towards value-based healthcare and cost-effectiveness as healthcare systems in the region look for solutions that deliver accurate diagnoses efficiently and at a reasonable cost is providing a considerable boost to the market growth. Besides this, the launch of biopsy devices that offer high-quality samples, quicker turnaround times, and compatibility with modern diagnostic platforms are supporting the market growth. Looking forward, the market value is projected to reach USD 1,110.1 Million by 2034, expanding at a CAGR of 5.67% during 2026-2034.

Market Summary:

• Based on the procedure type, the market has been bifurcated as surgical and needle biopsy.
• On the basis of the product, the market has been divided into biopsy guidance systems, needle-based biopsy guns, biopsy needles, biopsy forceps and others.
• Based on the application, the market has been classified as breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy and others.
• On the basis of the guidance-technique, the market has been categorized as ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy and others.
• Based on the end-user, the market has been divided into hospitals and clinics, academic and research institutes and others.
• Country-wise, the market has been segmented into Germany, France, the United Kingdom, Italy, Spain and others.
• The competitive landscape of the market has also been examined along with the profile of the key players.

Report Coverage:

Report Features	Details
Base Year of the Analysis	2025
Historical Period	2020-2025
Forecast Period	2026-2034
Units	Million USD
Segment Coverage	Procedure Type, Product, Application, Guidance Technique, End User, Country
Countries Covered	Germany, France, United Kingdom, Italy, Spain, Others
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: [email protected]
Americas:- +1 631 791 1145🍷 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800